(Q38560161)

4 September 2017

title

Size effect on the antibody production induced by biodegradable microspheres containing antigen (English)

1 reference

biodegradable microsphere

4 September 2017

0 references

1 reference

1 reference

R Nakaoka

1

1 reference

4 September 2017

Y Inoue

series ordinal

2

1 reference

4 September 2017

Y Tabata

series ordinal

3

1 reference

4 September 2017

Y Ikada

series ordinal

4

1 reference

4 September 2017

language of work or name

English

0 references

publication date

1 September 1996

1 reference

4 September 2017

1 reference

4 September 2017

volume

14

1 reference

4 September 2017

issue

13

1 reference

4 September 2017

page(s)

1251-1256

1 reference

Current status of immunological adjuvants

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900016-3

7 January 2021

Possibilities of using nanoparticles as carriers for drugs and vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900016-3

7 January 2021

Potential of polymer microencapsulation technology for vaccine innovation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900016-3

7 January 2021

Biodegradable microspheres. XIII: Immune response to the DNP hapten conjugated to polyacryl starch microparticles.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900016-3

7 January 2021

Controlled-release vaccines--biodegradable polylactide/polyglycolide (PL/PG) microspheres as antigen vehicles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900016-3

7 January 2021

Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly(L-lactic acid) microspheres in rats, rabbits and guinea-pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900016-3

7 January 2021

Protection against vaginal SIV transmission with microencapsulated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900016-3

7 January 2021

Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900016-3

7 January 2021

Macrophage phagocytosis of biodegradable microspheres composed of L-lactic acid/glycolic acid homo- and copolymers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900016-3

7 January 2021

Polyanhydride microspheres that display near-constant release of water-soluble model drug compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900016-3

7 January 2021

Protein measurement by ninhydrin determination of amino acids released by alkaline hydrolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900016-3

7 January 2021

Tolerance to rat monoclonal antibodies. Implications for serotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900016-3

7 January 2021

Influence of the particle size on the adjuvant effect of particulate polymeric adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900016-3

7 January 2021

Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900016-3

7 January 2021

10.1016/S0264-410X(96)00016-3

Identifiers

DOI

1 reference

4 September 2017

1 reference